Cargando…

Identification of an immunotherapy-responsive molecular subtype of bladder cancer

BACKGROUND: Although various molecular subtypes of bladder cancer (BC) have been investigated, most of these studies have focused on muscle-invasive BC (MIBC). A few studies have investigated non-muscle-invasive BC (NMIBC) or NMIBC and MIBC together, but none has classified progressive NMIBC or immu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Song, Bic-Na, Kim, Seon-Kyu, Mun, Jeong-Yeon, Choi, Young-Deuk, Leem, Sun-Hee, Chu, In-Sun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2019
Materias:	Research paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6921227/ https://www.ncbi.nlm.nih.gov/pubmed/31735557 http://dx.doi.org/10.1016/j.ebiom.2019.10.058

Ejemplares similares

Bioinformatic identification of prognostic signature defined by copy number alteration and expression of CCNE1 in non-muscle invasive bladder cancer
por: Song, Bic-Na, et al.
Publicado: (2017)

YAP1 activation is associated with the progression and response to immunotherapy of non-muscle invasive bladder cancer
por: Baek, Seung-Woo, et al.
Publicado: (2022)

Fanconi Anemia Pathway Activation by FOXM1 is Critical to Bladder Cancer Recurrence and Anticancer Drug Resistance
por: Roh, Yun-Gil, et al.
Publicado: (2020)

Stepwise molecular mechanisms responsible for chemoresistance in bladder cancer cells
por: Mun, Jeong-Yeon, et al.
Publicado: (2022)

A gene expression signature of FOXM1 predicts the prognosis of hepatocellular carcinoma
por: Song, Bic-Na, et al.
Publicado: (2018)

E2F1 Promotes Progression of Bladder Cancer by Modulating RAD54L Involved in Homologous Recombination Repair
por: Mun, Jeong-Yeon, et al.
Publicado: (2020)

Transcriptional Profiling of Advanced Urothelial Cancer Predicts Prognosis and Response to Immunotherapy
por: Baek, Seung-Woo, et al.
Publicado: (2020)

Identification of a molecular signature of prognostic subtypes in diffuse-type gastric cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2019)

Identification of S100A8-correlated genes for prediction of disease progression in non-muscle invasive bladder cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2010)

Genomic Signature of the Standardized Uptake Value in (18)F-Fluorodeoxyglucose Positron Emission Tomography in Breast Cancer
por: Kim, Seon-Kyu, et al.
Publicado: (2020)

Identification of the cuproptosis-related molecular subtypes and an immunotherapy prognostic model in hepatocellular carcinoma
por: Zhang, Li, et al.
Publicado: (2022)

VNTR polymorphism in the breakpoint region of ABL1 and susceptibility to bladder cancer
por: Kim, Min-Hye, et al.
Publicado: (2021)

Update on bladder cancer molecular subtypes
por: Fong, Megan Hoi Yan, et al.
Publicado: (2020)

Identification of endothelial-related molecular subtypes for bladder cancer patients
por: Li, Deng-xiong, et al.
Publicado: (2023)

Multiomics analysis of ferroptosis-related molecular subtypes in muscle-invasive bladder cancer immunotherapy
por: Wang, Haojie, et al.
Publicado: (2022)

DNA Methylation Modification Map to Predict Tumor Molecular Subtypes and Efficacy of Immunotherapy in Bladder Cancer
por: Ye, Fangdie, et al.
Publicado: (2021)

A Molecular Signature Determines the Prognostic and Therapeutic Subtype of Non-Muscle-Invasive Bladder Cancer Responsive to Intravesical Bacillus Calmette-Guérin Therapy
por: Kim, Seon-Kyu, et al.
Publicado: (2021)

Dual Relationship Between Stromal Cells and Immune Cells in the Tumor Microenvironment
por: Mun, Jeong-Yeon, et al.
Publicado: (2022)

Apoptosis related genes mediated molecular subtypes depict the hallmarks of the tumor microenvironment and guide immunotherapy in bladder cancer
por: Zhou, Liquan, et al.
Publicado: (2023)

Therapeutic responses to chemotherapy or immunotherapy by molecular subtype in bladder cancer patients: A meta-analysis and systematic review
por: Wang, Shunde, et al.
Publicado: (2023)

Identification and Validation of Immune Molecular Subtypes in Pancreatic Ductal Adenocarcinoma: Implications for Prognosis and Immunotherapy
por: Li, Ruiyu, et al.
Publicado: (2021)

Identification of molecular subtypes based on liquid–liquid phase separation and cross-talk with immunological phenotype in bladder cancer
por: Sun, Le, et al.
Publicado: (2022)

Identification and Validation of the Immune Subtypes of Lung Adenocarcinoma: Implications for Immunotherapy
por: Song, Yang, et al.
Publicado: (2020)

Tumor Microenvironment Analysis Identified Subtypes Associated With the Prognosis and the Tumor Response to Immunotherapy in Bladder Cancer
por: Zhang, Hongxian, et al.
Publicado: (2021)

Research Note: Evaluation of the cross protective efficacy of a subtype B aMPV vaccine against virulent subtype A aMPV by different administration routes
por: Youn, Ha-Na, et al.
Publicado: (2022)

Identification and validation of molecular subtypes’ characteristics in bladder urothelial carcinoma based on autophagy-dependent ferroptosis
por: Liu, Shiwei, et al.
Publicado: (2023)

Identification of bladder cancer subtypes and predictive model for prognosis, immune features, and immunotherapy based on neutrophil extracellular trap-related genes
por: Guo, Changhong, et al.
Publicado: (2023)

Molecular subtyping bladder cancer: Is it ready for clinical practice?
por: VAKAR LOPEZ, Funda
Publicado: (2020)

Integrated molecular analyses of an interferon-γ based subtype with regard to outcome, immune characteristics, and immunotherapy in bladder cancer and experimental verification
por: Wang, Jirong, et al.
Publicado: (2022)

M7G-related molecular subtypes can predict the prognosis and correlate with immunotherapy and chemotherapy responses in bladder cancer patients
por: Li, Deng-xiong, et al.
Publicado: (2023)

Identification of subtypes correlated with tumor immunity and immunotherapy in cutaneous melanoma
por: Liu, Qian, et al.
Publicado: (2021)

Identification of immunotherapy and chemotherapy-related molecular subtypes in colon cancer by integrated multi-omics data analysis
por: Zhu, Jie, et al.
Publicado: (2023)

Epigenetic profiling demarcates molecular subtypes of muscle-invasive bladder cancer
por: van der Vos, K. E., et al.
Publicado: (2020)

Molecular subtype identification and signature construction based on Golgi apparatus-related genes for better prediction prognosis and immunotherapy response in hepatocellular carcinoma
por: Sun, Liang, et al.
Publicado: (2023)

Epigenetic regulation of mammalian Hedgehog signaling to the stroma determines the molecular subtype of bladder cancer
por: Kim, SungEun, et al.
Publicado: (2019)

Identification of tumor antigens and immunogenic cell death-related subtypes for the improvement of immunotherapy of breast cancer
por: Cao, Xi, et al.
Publicado: (2022)

Clinical value of anoikis-related genes and molecular subtypes identification in bladder urothelial carcinoma and in vitro validation
por: Dong, Ying, et al.
Publicado: (2023)

Impact of HIV-1 subtype and Korean Red Ginseng on AIDS progression: comparison of subtype B and subtype D
por: Cho, Young-Keol, et al.
Publicado: (2019)

BCG in Bladder Cancer Immunotherapy
por: Jiang, Song, et al.
Publicado: (2022)

Risk Classification of Bladder Cancer by Gene Expression and Molecular Subtype
por: Blanca, Ana, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rve1hud1oshr8f24j9hrkls9hc